Last reviewed · How we verify
POVIDONE
At a glance
| Generic name | POVIDONE |
|---|---|
| Drug class | Antiseptic [EPC] |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Durability of Three Monthly Loading Doses With Faricimab in Treatment-naïve Neovascular Age-related Macular Degeneration
- IRELAnD: Investigating the Role of Early Low-dose Aspirin in Diabetes (PHASE3)
- Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants (PHASE3)
- Comparison of Pain Reduction in Painful Chronic Wounds With and Without Fat Grafting (NA)
- Surgical Site Preparation in Subjects Undergoing Medical Thoracoscopy (NA)
- Efficacy of Autologous Conditioned Serum in Temporomandibular Joint Disorder (NA)
- Preoperative Clindamycin Vaginal Cream Versus Vaginal Cleansing With Povidone-iodine on Postoperative Infections After Cesarean Section (PHASE4)
- CLinical Evaluation of ANtiseptic Skin Preparation in Revision Total Joint Arthroplasty of the Hip and Knee (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- POVIDONE CI brief — competitive landscape report
- POVIDONE updates RSS · CI watch RSS